EirGenix is Taiwan’s largest contract development and manufacturing organization (CDMO) specialising in both mammalian and microbial-derived biologics. The company provides comprehensive, one-stop services that cover the entire spectrum from pre-clinical development to commercial manufacturing. EirGenix boasts extensive experience with a range of biologics, including monoclonal and bi/poly-specific antibodies, recombinant proteins, antibody-drug conjugates (ADCs), and plasmid DNAs. It is noteworthy that EirGenix is the only CDMO in Taiwan with biomanufacturing facilities that have received approval from multiple international regulatory authorities, including the US FDA, Japan PMDA, Australia TGA, and EU EMA.

Services include:
– Biologics
– Drug Substance Manufacturing (API)
– Drug Product Formulation (FDF)
– Regulatory Services
– Analytical Methods Development

EirGenix is dedicated to offering top-tier manufacturing solutions and has established itself as a trusted partner within the pharmaceutical industry. For more information, please visit eirgenix.com.